Skip to main content

Table 4 Correlation between tumor size and CT-based therapeutic response in the study population

From: Comparison between RECIST and PERCIST criteria in therapeutic response assessment in cases of lymphoma

 

Therapeutic response by RECIST

Test value#

P value

Sig.

CR

PR

SD

PD

Base (sum)

 Median (IQR)

35 (22.5–46.75)

69.5 (47.5–95)

35 (17–39.7)

77.5 (33.75–136.5)

7.821

0.050

S

 Range

7.5–63

8.5–125

17–39.7

3.5–182

End (sum)

 Median (IQR)

0 (0–0)

28.5 (6.2–36.5)

29 (16.8–37)

26.5 (13–61)

16.771

0.001

HS

 Range

0–0

1–78

16.8–37

0–95

Tumor reduction (%)

 Median (IQR)

100 (100–100)

65.5 (52–76)

6 (0.01–17)

59 (47–70)

22.206

0.000

HS

 Range

100–100

31–91

0.01–17

47–70

  1. P value > 0.05 Non-significant (NS), P value < 0.05 Significant (S), P value < 0.01 Highly significant (HS)
  2. # Kruskal–Wallis test